Abbott, a global healthcare company, releases its fourth quarter 2013 results: to evaluate the fourth quarter they got off of 44%, penalized by the impact of split from the subsidiary AbbVie Inc., specialized in pharmaceuticals of business, though the operations of the remaining product company health have experienced growth solid.
AbbVie but he had contributed but $1,58 billion nell'exercise previous: group profit thus fell to 589 million dollars, one 37 cents per share, respect to 1,05 billion dollars, o 66 cents per share, from a year ago. Excluding the impacts the spin off and other operations, the useful rectified by continuous operations went up to 58 cents from 48 cents. Revenues have increased 0,4% a 5,66 billion dollars, increasing of 3,3% excluding the impacts of currency.
